Tubal ligation and the risk of ovarian cancer: review and meta-analysis

被引:191
作者
Cibula, D. [1 ]
Widschwendter, M. [2 ]
Majek, O. [3 ]
Dusek, L. [3 ]
机构
[1] Charles Univ Prague, Oncogynecol Ctr, Dept Obstet & Gynecol, Gen Teaching Hosp,Med Sch 1, Prague 2, Czech Republic
[2] UCL, Inst Womens Hlth, Dept Gynecol Oncol, London, England
[3] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic
关键词
tubal ligation; BRCA mutation; ovarian cancer; meta-analysis; ORAL-CONTRACEPTIVE USE; HISTOLOGIC TYPE; COLLABORATIVE ANALYSIS; REPRODUCTIVE HISTORY; HORMONAL FACTORS; BRCA2; MUTATIONS; CARRIERS; STERILIZATION; EXPOSURE; WOMEN;
D O I
10.1093/humupd/dmq030
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
background: The reduction of ovarian cancer (OC) risk in women with a history of tubal ligation (TL) has been reported repeatedly, mostly on small populations. We have aimed to provide a critical overview of the studies available to date and to conduct a meta-analysis. methods: There were 40 relevant studies identified. The studies were divided into two groups for strict and extended meta-analysis, respectively. Subgroup analysis was performed for age, time dependency since TL, histological types of OC and BReast CAncer (BRCA) mutation. results: Meta-analysis of 13 strictly selected studies showed a reduced risk of epithelial OC by 34%. The protective effect of TL was confirmed even in a subgroup of women 10-14 years after the procedure. The risk reduction was confirmed for the endometrioid (RR=0.40) and serous (RR=0.73) cancers but not for mucinous. conclusions: The review of relevant articles, as well as the meta-analysis of selected studies, yields consistent data on a significant reduction of OC risk in women who had undergone TL. The results of this meta-analysis should provide an impulse for further research on the etiology of ovarian epithelial cancers, focusing particularly on the importance of retrograde transport of endometrial cells.
引用
收藏
页码:55 / 67
页数:13
相关论文
共 52 条
[31]  
MORI M, 1984, CANCER-AM CANCER SOC, V53, P2746, DOI 10.1002/1097-0142(19840615)53:12<2746::AID-CNCR2820531235>3.0.CO
[32]  
2-P
[33]   Endometrioid and clear cell ovarian cancers - A comparative analysis of risk factors [J].
Nagle, Christina M. ;
Olsen, Catherine M. ;
Webb, Penelope M. ;
Jordan, Susan J. ;
Whiteman, Dauid C. ;
Green, Adele C. .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (16) :2477-2484
[34]  
Narod SA, 2002, JNCI-J NATL CANCER I, V94, P1773, DOI 10.1093/jnci/94.23.1773
[35]   Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations:: a case-control study [J].
Narod, SA ;
Sun, P ;
Ghadirian, P ;
Lynch, H ;
Isaacs, C ;
Garber, J ;
Weber, B ;
Karlan, B ;
Fishman, D ;
Rosen, B ;
Tung, N ;
Neuhausen, SL .
LANCET, 2001, 357 (9267) :1467-1470
[36]   Oral contraceptives, other methods of contraception, and risk reduction for ovarian cancer [J].
Ness, RB ;
Grisso, JA ;
Vergona, R ;
Klapper, J ;
Morgan, M ;
Wheeler, JE .
EPIDEMIOLOGY, 2001, 12 (03) :307-312
[37]   Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study [J].
Pike, MC ;
Pearce, CL ;
Peters, R ;
Cozen, W ;
Wan, P ;
Wu, AH .
FERTILITY AND STERILITY, 2004, 82 (01) :186-195
[38]   REPRODUCTIVE AND OTHER FACTORS AND RISK OF EPITHELIAL OVARIAN-CANCER - AN AUSTRALIAN CASE-CONTROL STUDY [J].
PURDIE, D ;
GREEN, A ;
BAIN, C ;
SISKIND, V ;
WARD, B ;
HACKER, N ;
QUINN, M ;
WRIGHT, G ;
RUSSELL, P ;
SUSIL, B .
INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (06) :678-684
[39]   Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations [J].
Rebbeck, TR ;
Lynch, HT ;
Neuhausen, SL ;
Narod, SA ;
van't Veer, L ;
Garber, JE ;
Evans, G ;
Isaacs, C ;
Daly, MB ;
Matloff, E ;
Olopade, OI ;
Weber, BL .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) :1616-1622
[40]  
Risch HA, 1996, AM J EPIDEMIOL, V144, P363, DOI 10.1093/oxfordjournals.aje.a008937